Skip to main content
Caplight Logo









Vivan Therapeutics

Vivan Therapeutics

Private
LondonHealthcare & Life Scienceshttps://www.vivantx.com/

Last Round

VC Round

Nov 3, 2025

Total Funding Raised

$5.5M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Vivan Therapeutics is a biotechnology company that provides a personalized cancer therapeutics platform utilizing fruit fly avatars and AI to test drug combinations and recommend treatments.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

personalized oncologyprecision medicinefruit fly avatarspatient avatarsin-vivo screeningcombination therapydrug discovery serviceshigh-throughput screeningoncology AIclinical decision supportdrug repurposingdisease modelingfly models of cancerhard-to-treat cancerscancer second opinion

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivan Therapeutics Comparables

Compare Vivan Therapeutics with similar companies based on industry and business-model similarity.

Vivan Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Xilis
83%
SageMedic Corp.
79%
Tempus
78%

Vivan Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundNov 3, 2025
GrantMay 1, 2021

Vivan Therapeutics Investors

Notable investors and investment history

Vivan Therapeutics investors
InvestorRounds
Granatus VenturesSeed
Freya VenturesSeed
Innovate UKGrant
Reflect VenturesSeed
Hub71VC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 43% MoM.

  • Nov 3, 2025

    Raised $5M from Hub71.

Vivan Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vivan Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vivan Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range17
Year Founded2018
Last FundingNov 3, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?